<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(1)</volume><submitter>Liu S</submitter><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Acute type A aortic dissection is a life-threatening cardiovascular disease commonly seen in emergency department, resulting in substantial mortality and morbidity. We aimed to investigate the prognostic value of N-terminal pro-B type natriuretic peptide (NT-proBNP) among this critically ill population.&lt;h4>Design&lt;/h4>The design of this study was a retrospective cohort study.&lt;h4>Setting&lt;/h4>The study population was recruited in the Emergency Department of Fuwai hospital in China from 2018 to 2020.&lt;h4>Participants&lt;/h4>We consecutively enrolled 829 patients with acute type A aortic dissection and measurable baseline NT-proBNP.&lt;h4>Primary outcome&lt;/h4>The primary endpoint was 1-year all-cause death.&lt;h4>Results&lt;/h4>Based on tertiles of NT-proBNP (pg/mL), patients were stratified into low (≤150.3, n=276), intermediate (150.3-667.6, n=277) and high (>667.6, n=276) NT-proBNP groups. Compared with patients with low NT-proBNP, the Kaplan-Meier estimates for primary 1-year mortality were higher in intermediate (32.5% vs 18.1%; HR 1.91, 95% CI 1.35 to 2.69) and high (42.0% vs 18.1%; HR 2.56, 95% CI 1.84 to 3.57) NT-proBNP groups, respectively. After multivariable regression adjusted for confounders, NT-proBNP tertiles were independent predictors for 1-year mortality (adjusted HR for intermediate group 1.52, 95% CI 1.02 to 2.27; adjusted HR for high group 2.17, 95% CI 1.41 to 3.32). Notably, the predictive performance of NT-proBNP for 1-year mortality was greater in patients receiving surgery than conservative treatment (between-cohorts difference in area under the curve 0.13, Delong's test p=0.04).&lt;h4>Conclusion&lt;/h4>NT-proBNP provides incremental prognostic information for mortality in patients with acute type A aortic dissection who underwent surgical repairment, which could aid in risk stratification as a pragmatic and versatile biomarker in this critically ill population while having limited prognostic value for those receiving conservative treatment.</pubmed_abstract><journal>BMJ open</journal><pagination>e093757</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11781122</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Clinical implication of NT-proBNP to predict mortality in patients with acute type A aortic dissection: a retrospective cohort study.</pubmed_title><pmcid>PMC11781122</pmcid><pubmed_authors>Fu R</pubmed_authors><pubmed_authors>Yuan S</pubmed_authors><pubmed_authors>Dou K</pubmed_authors><pubmed_authors>Liu Q</pubmed_authors><pubmed_authors>Song C</pubmed_authors><pubmed_authors>Gao J</pubmed_authors><pubmed_authors>Cui X</pubmed_authors><pubmed_authors>Liu S</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Zhang R</pubmed_authors><pubmed_authors>Liu W</pubmed_authors><pubmed_authors>Qin S</pubmed_authors><pubmed_authors>Zhu C</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Bian X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical implication of NT-proBNP to predict mortality in patients with acute type A aortic dissection: a retrospective cohort study.</name><description>&lt;h4>Objectives&lt;/h4>Acute type A aortic dissection is a life-threatening cardiovascular disease commonly seen in emergency department, resulting in substantial mortality and morbidity. We aimed to investigate the prognostic value of N-terminal pro-B type natriuretic peptide (NT-proBNP) among this critically ill population.&lt;h4>Design&lt;/h4>The design of this study was a retrospective cohort study.&lt;h4>Setting&lt;/h4>The study population was recruited in the Emergency Department of Fuwai hospital in China from 2018 to 2020.&lt;h4>Participants&lt;/h4>We consecutively enrolled 829 patients with acute type A aortic dissection and measurable baseline NT-proBNP.&lt;h4>Primary outcome&lt;/h4>The primary endpoint was 1-year all-cause death.&lt;h4>Results&lt;/h4>Based on tertiles of NT-proBNP (pg/mL), patients were stratified into low (≤150.3, n=276), intermediate (150.3-667.6, n=277) and high (>667.6, n=276) NT-proBNP groups. Compared with patients with low NT-proBNP, the Kaplan-Meier estimates for primary 1-year mortality were higher in intermediate (32.5% vs 18.1%; HR 1.91, 95% CI 1.35 to 2.69) and high (42.0% vs 18.1%; HR 2.56, 95% CI 1.84 to 3.57) NT-proBNP groups, respectively. After multivariable regression adjusted for confounders, NT-proBNP tertiles were independent predictors for 1-year mortality (adjusted HR for intermediate group 1.52, 95% CI 1.02 to 2.27; adjusted HR for high group 2.17, 95% CI 1.41 to 3.32). Notably, the predictive performance of NT-proBNP for 1-year mortality was greater in patients receiving surgery than conservative treatment (between-cohorts difference in area under the curve 0.13, Delong's test p=0.04).&lt;h4>Conclusion&lt;/h4>NT-proBNP provides incremental prognostic information for mortality in patients with acute type A aortic dissection who underwent surgical repairment, which could aid in risk stratification as a pragmatic and versatile biomarker in this critically ill population while having limited prognostic value for those receiving conservative treatment.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2025-04-04T22:23:59.864Z</modification><creation>2025-04-04T22:23:59.864Z</creation></dates><accession>S-EPMC11781122</accession><cross_references><pubmed>39880420</pubmed><doi>10.1136/bmjopen-2024-093757</doi></cross_references></HashMap>